144 funds took holdings and 456 increased holdings.
CVS Health stock opened at $65.52 on Friday. Highland Cap Mngmt Ltd invested in 0.65% or 115,516 shares. The stock of CVS Health Corporation (NYSE:CVS) earned "Hold" rating by Goldman Sachs on Thursday, November 29. Jnba Fin Advsrs holds 1.72% or 48,654 shares in its portfolio. Commerzbank Aktiengesellschaft Fi invested in 0.12% or 156,199 shs. Bollard Gru Llc holds 17,775 shares. Washington Tru Savings Bank accumulated 2,310 shares. Cwm Ltd Liability has 2,404 shs.
Since August 27, 2018, it had 0 insider buys, and 7 insider sales for $18.41 million activity. Also, CFO David M. Denton sold 25,159 shares of the business's stock in a transaction on Thursday, November 29th. $1.17 million worth of CVS Health Corporation (NYSE:CVS) was sold by Brennan Troyen A on Wednesday, November 14. St James Investment Limited Liability Corporation invested 5.26% in CVS Health Corporation (NYSE:CVS). Bisaccia Lisa sold $1.72 million worth of CVS Health Corporation (NYSE:CVS) on Monday, October 1. The shares were sold at an average price of $69.04, for a total transaction of $11,486,046.72. Insiders have sold 205,756 shares of company stock worth $14,668,815 over the last quarter.
While the disagreement between the two companies reportedly centered on prescription fulfillment fees, the press release did not disclose the agreement's financial terms.
"The stock has come under pressure in the last month and this has been a driver". About 12.60M shares traded or 30.89% up from the average.
In recent weeks, top market experts have given their professional, in-depth analysis of CVS Health Corporation (NYSE: CVS). CVS outperformed by 3.17% the S&P500. MCF Advisors LLC lifted its stake in CVS Health by 284.1% in the 3rd quarter. It also increased its holding in Mastercard Incorporated Cl A (NYSE:MA) by 45,941 shares in the quarter, for a total of 71,922 shares, and has risen its stake in Select Sector Spdr Tr Communic.
CVS Health (NYSE:CVS) last issued its quarterly earnings results on Tuesday, November 6th. The institutional investor held 1.18M shares of the medical and nursing services company at the end of 2018Q3, valued at $92.61 million, up from 922,297 at the end of the previous reported quarter. This year's EPS analyst estimate is awaited to be $2.14. The pharmacy operator reported $1.73 EPS for the quarter, topping analysts' consensus estimates of $1.71 by $0.02. Finally, Cantor Fitzgerald began coverage on CVS Health in a report on Sunday, December 2nd. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: Benzinga.com and their article: "40 Stocks Moving In Friday's Pre-Market Session - Benzinga" published on January 18, 2019 as well as Bizjournals.com's news article titled: "Disney nominates CVS executive to board - L.A. Biz" with publication date: January 11, 2019. 67% are bullish. 6 are the (NYSE:CVS)'s analyst reports since September 17, 2018 according to StockzIntelligence Inc. Leerink Swann lifted their price objective on CVS Health from $85.00 to $95.00 and gave the company a "positive" rating in a research note on Thursday, November 8th. Hourican Kevin sold $642,300 worth of CVS Health Corporation (NYSE:CVS) or 8,564 shs on Monday, August 27. The company has focused on affordable prices for a while now, even providing some generic medications for $4. They issued a peer perform rating on the stock.
- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.